Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.
Visram A, De La Torre A, White D, Su J, Masih-Khan E, Chu M, Jimenez-Zepeda V, McCurdy A, LeBlanc R, Song K, Mian H, Louzada M, Sebag M, Bergstrom D, Stakiw J, Reiman A, Kotb R, Aslam M, Venner C, Kaedbey R, Gul E, Reece D.
Visram A, et al. Among authors: su j.
Blood Cancer J. 2023 Dec 8;13(1):181. doi: 10.1038/s41408-023-00946-z.
Blood Cancer J. 2023.
PMID: 38065967
Free PMC article.